FDA inspection

Shreepati Pharmaceuticals Private Ltd.: FDA inspection ending Dec 2, 2023

FDA inspection 1226379 · Voluntary Action Indicated (VAI) · Dhar

Key facts

Inspection ID 1226379
Firm Shreepati Pharmaceuticals Private Ltd.
FEI number 3005515162
Address Sector I, 1 Pithampur Industrial Area; Survey No : 184
City Dhar
Fiscal year 2024
Inspection end date Dec 2, 2023
Classification Voluntary Action Indicated (VAI)
Project area Generic Drug Evaluation
Product type Drugs

At a glance

  • None Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections